Palermo, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 11.791
NA - Nord America 1.626
AS - Asia 676
SA - Sud America 141
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 14.278
Nazione #
IT - Italia 9.508
US - Stati Uniti d'America 1.570
DE - Germania 615
NL - Olanda 559
SE - Svezia 319
SG - Singapore 225
CN - Cina 200
FR - Francia 200
UA - Ucraina 126
BR - Brasile 120
GB - Regno Unito 97
IE - Irlanda 80
IN - India 72
CH - Svizzera 57
ID - Indonesia 50
CA - Canada 43
RU - Federazione Russa 36
FI - Finlandia 35
BE - Belgio 30
PL - Polonia 24
ES - Italia 23
TR - Turchia 20
JP - Giappone 19
MA - Marocco 13
HK - Hong Kong 11
AT - Austria 10
AL - Albania 9
VN - Vietnam 9
AR - Argentina 8
GR - Grecia 8
RO - Romania 8
IR - Iran 7
KR - Corea 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CZ - Repubblica Ceca 6
MX - Messico 6
TH - Thailandia 6
TW - Taiwan 6
BD - Bangladesh 5
EU - Europa 5
IL - Israele 5
IQ - Iraq 5
PA - Panama 5
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
CL - Cile 4
HU - Ungheria 4
LT - Lituania 4
PK - Pakistan 4
PT - Portogallo 4
SM - San Marino 4
BG - Bulgaria 3
EC - Ecuador 3
EG - Egitto 3
KG - Kirghizistan 3
MD - Moldavia 3
PE - Perù 3
RS - Serbia 3
TN - Tunisia 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CV - Capo Verde 2
DK - Danimarca 2
HR - Croazia 2
IS - Islanda 2
JO - Giordania 2
LK - Sri Lanka 2
MT - Malta 2
MY - Malesia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ME - Montenegro 1
NO - Norvegia 1
NP - Nepal 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 14.278
Città #
Milan 978
Rome 737
Chandler 347
Naples 309
Turin 199
Florence 154
Singapore 145
Ashburn 144
Bologna 139
Palermo 123
Bari 98
Genoa 89
Catania 86
Dublin 78
Jacksonville 74
Ann Arbor 73
San Mateo 69
Verona 63
Wilmington 54
Brescia 52
Venice 49
Jakarta 46
Padova 45
Los Angeles 43
Nanjing 43
Parma 38
Bergamo 37
Messina 36
Taranto 34
Frankfurt am Main 33
Bremen 32
New York 32
Cagliari 31
Dearborn 31
Pescara 30
Perugia 29
Reggio Emilia 29
Ottawa 28
Salerno 28
Cattolica 25
Hyderabad 25
Livorno 25
Munich 25
Brussels 24
Nürnberg 24
Redwood City 24
The Dalles 24
Marseille 23
Lawrence 22
Lucca 22
Modena 21
Moscow 21
Rimini 21
Woodbridge 21
Monza 20
Novara 20
Trieste 20
Boston 19
Falls Church 16
Nanchang 16
Princeton 16
Houston 15
Lancaster 15
São Paulo 15
Lecce 14
Caserta 13
Cesano Maderno 12
Piacenza 12
Hong Kong 11
Lamezia Terme 11
Mountain View 11
Redmond 11
Tianjin 11
Udine 11
Vicenza 11
Zurich 11
Ancona 10
Chicago 10
Düsseldorf 10
Kraków 10
Pavia 10
Pisa 10
Porto Sant'Elpidio 10
Terni 10
Trento 10
Beijing 9
Bolzano 9
Catanzaro 9
Hefei 9
Kunming 9
Macerata 9
Nova Milanese 9
Orta di Atella 9
Pordenone 9
Rende 9
San Benedetto del Tronto 9
Sant'Anastasia 9
Seattle 9
Amsterdam 8
Angri 8
Totale 5.566
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 10.098
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 369
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 265
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 155
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 150
Urological complications following inguinal hernioplasty 144
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 136
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 130
Hot topics in urological health economics. A mini review 122
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 121
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 116
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 111
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 106
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 105
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 104
Imaging in prostate cancer staging: present role and future perspectives 102
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 99
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 99
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 98
Therapeutic strategies in penile cancer: state of the art 98
The occult urothelial cancer 98
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 91
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 90
Focal surgery in testis cancer: current state of the art 84
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 78
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 77
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 77
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 73
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 70
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 69
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 67
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 65
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer 62
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 61
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 54
Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta-analysis 54
[Sport, infertility and erectile dysfunction] 51
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 48
How to reduce bacillus Calmette-Guérin discontinuation in patients with severe functional impairment 40
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 34
The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer 33
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 32
Bladder tumor markers: A review of the literature 32
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 31
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 29
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 29
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 28
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 26
Imaging in bladder cancer: Present role and future perspectives 26
Totale 14.337
Categoria #
all - tutte 29.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039 0 0 0 0 0 0 0 0 0 0 0 39
2020/2021360 10 28 14 30 56 29 45 13 36 13 58 28
2021/2022464 38 29 5 38 36 35 15 62 26 37 69 74
2022/20232.159 173 150 88 196 85 180 98 181 228 174 351 255
2023/20244.326 258 336 300 332 323 346 369 399 343 431 438 451
2024/20255.884 471 574 579 527 605 485 507 516 630 414 442 134
Totale 14.337